Innospec (IOSP) EBT (2010 - 2026)

Innospec has disclosed EBT across 17 years of filings, most recently posting $39.9 million for Q1 2026.

• EBT for Q1 2026 came in at $39.9 million, down 11.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.4 million (down 31.19% YoY), and the FY2025 annual result was $25.9 million, down 37.14% from the prior year.
• EBT came in at $39.9 million for Q1 2026 at Innospec, up from -$61.9 million in the prior quarter.
• In the past five years, EBT ranged from a high of $55.3 million in Q1 2024 to a low of -$102.6 million in Q4 2024.
• The 5-year median for EBT is $43.7 million (2024), against an average of $22.8 million.
• Across the five-year window, EBT jumped 193.2% in 2022 and tumbled 202.65% in 2024, its largest moves.
• Innospec's EBT stood at $45.2 million in 2022, then sank by 175.0% to -$33.9 million in 2023, then sank by 202.65% to -$102.6 million in 2024, then surged by 39.67% to -$61.9 million in 2025, then surged by 164.46% to $39.9 million in 2026.
• The last three EBT figures came in at $39.9 million (Q1 2026), -$61.9 million (Q4 2025), and $11.5 million (Q3 2025), per Business Quant data.